2025 Partners
LIDE - Expertise Partner
LIDE is an award-winning oncology contract research organization with 12 years of delivering drug evaluation services to 200+ clients worldwide. We offer traditional preclinical CRO services like pharmacology, PK, and biomarker studies with 70+ CDX models and 2000 patient-derived xenograft (PDX) models. Our library covers 50+ cancer types and 200+ models harbor special naturally-occurred drug-resistant and/or genetic alterations. Ask us about our proprietary tools for in-vivo drug validation in 7-10 days.
GemPharmatech - Expertise Partner
GemPharmatech is a leading company in China to provide high-quality animal model resources and services for the biomedical community as well as pharmaceutical companies. Based on more than 16 ears' practice in laboratory animals of the former entity. GemPharmatech has the vision and is striving to become one of the best one-stop service center for production, distribution, and phenotyping of gene-modified mouse models for partners all across the world.
Certis Oncology Solutions - Expertise Partner
Certis Oncology Solutions is a life science technology company committed to realizing the promise of precision oncology. Our product is “Oncology Intelligence™”—highly predictive therapeutic response data derived from advanced biological models of cancer. Our proprietary platform informs individual treatment decisions and accelerates the development of new cancer therapies. We partner with therapeutics developers to help close the problematic translation gap between preclinical studies and clinical trials. Through more clinically relevant, well-characterized and annotated models, advanced imaging technology and thoughtfully designed studies, Certis brings greater certainty to go/no-go development decisions.
genOway - Expertise Partner
genOway is a biotechnology company offering preclinical models and solutions, especially genetically-modified mouse, rat and cell line models, to biopharmaceutical companies, CROs and academic institutions worldwide. Its goal is to provide ultimate predictability in preclinical research to help its clients select the best therapeutics to accelerate drug development from bench to bedside.
WuXi AppTec - Program Partner
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients.
WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.
TD2 - Program Partner
TD2 Translational Drug Development
We are your scientifically driven and flexible partner for drug development. Our team is fully dedicated to oncology – it is al we do – combining innovation and expertise to quickly move your therapies from preclinical development into clinical trials. Adaptive and forward-thinking – we guide your therapy through the most critical development milestones from the lab to planning your regulatory and clinical strategy and ultimately approved.
Champions Oncology - Exhibition Partner
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development lifecycle. From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patientderived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting today’s needs and innovating for tomorrow’s challenges.
Studylog - Exhibition Partner
Studylog's Animal Study Workflow Software® is designed for biomedical animal research and provides features for the design, planning, execution, analysis, and reporting of animal studies in a standardized, highly efficient manner, while protecting data integrity. Reducing many labs’ study-related labor by half, Studylog automates and streamlines the entire animal study process, making it easier, faster and cheaper, so researchers have more time and resources to get their job done.
EPO-Berlin - Exhibition Partner
EPO-Berlin brings over 25 years of expertise in Preclinical Oncology Models and Services. We offer 1000+ Highly Characterized in vivo PDX Models and in vitro PDX-Derived Cell Lines. We also offer CDX/Syngeneic Models, and Humanized Mouse Models (CD34/PBMC) Engrafted On-Site for Highest Quality Immuno-Oncology Studies. Our specialties include Immuno-Oncology Therapies (ADCs, ICIs, Antibodies & Bispecifics, Tumor Vaccines, Oncolytic Viruses), Radiotherapies (Radionuclides, Irradiation), Gene Therapies (AAVs, GalNAc-ASOs, LNPs), and Advanced Cell Therapies (CAR T/NK). We offer Live Mouse and Live Cell Imaging (Bioluminescent, Ultrasound), and In-House FlowCytometry, FACS, Necropsy, IHC Analysis. Our Comprehensive Services are Tailored for Groundbreaking Cancer Research.
